Arkolith/Insider Trading/CINC/Form 4

Healy James

Director, 10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Aug 15, 2022
Net Buying
Open-Market Buys
$15.2M
Open-Market Sells
$0
Net Open-Market Flow
$15.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2022Buy(P)500K$30.00$15.0M6.1M
Aug 11, 2022Buy(P)6K$30.00$180K6K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-091183) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML